当前位置:首页 - 行情中心 - 乐普医疗(300003) - 财务分析 - 资产负债表

乐普医疗

(300003)

  

流通市值:191.02亿  总市值:222.29亿
流通股本:16.16亿   总股本:18.81亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金3,340,861,662.253,609,445,553.314,130,387,971.164,220,754,806.78
应收票据及应收账款2,001,318,591.352,167,593,831.012,222,900,406.321,837,670,682.3
其中:应收票据102,456,414.5493,024,769.8893,222,618.184,509,973.95
应收账款1,898,862,176.812,074,569,061.132,129,677,788.221,753,160,708.35
应收款项融资107,981,361.6654,165,212.4663,430,547.4683,407,668.79
预付款项301,135,787.35317,762,713.1336,788,491.21320,471,238.27
其他应收款合计142,672,052.49155,668,664.95141,269,677.09110,449,885.41
存货2,216,459,996.882,265,395,093.912,217,579,109.362,289,473,586.38
一年内到期的非流动资产2,235,269.543,635,751.973,073,459.033,302,070.61
其他流动资产207,609,262.17199,945,164.46227,640,229.15184,703,896.89
流动资产平衡项目0000
流动资产合计8,732,636,190.039,213,054,214.629,612,306,637.999,325,437,615.04
非流动资产:
长期应收款935,793.46789,854.82,823,890.122,968,556.17
长期股权投资1,200,559,023.471,260,462,826.161,235,445,532.511,353,760,737.79
其他权益工具投资1,100,654,095.831,066,401,635.781,196,114,263.891,190,240,450.59
其他非流动金融资产26,500,00026,500,00026,500,00026,500,000
投资性房地产440,040,580.08387,507,016.45295,172,834.84296,774,138.94
固定资产4,049,534,377.674,120,888,129.032,780,381,468.612,812,962,375.74
在建工程541,283,433.55487,657,647.81,835,244,469.531,797,285,664.72
使用权资产362,963,401.57378,194,124.2355,119,435.28326,430,233.2
无形资产1,701,520,199.791,693,059,535.41,760,286,299.641,817,546,203.28
开发支出1,008,359,063.69985,038,877.38907,248,638.04861,745,696.38
商誉3,841,657,674.793,752,478,309.763,752,478,309.763,504,330,628.08
长期待摊费用310,650,492.41287,065,646.9279,566,936.64256,771,874.86
递延所得税资产166,667,350.55191,476,457.45160,282,878.65167,324,190.66
其他非流动资产1,522,322,713.211,445,823,443.871,309,553,984.271,282,253,121.24
非流动资产平衡项目0000
非流动资产合计16,273,648,200.0716,083,343,504.9815,896,218,941.7815,696,893,871.65
资产平衡项目0000
资产总计25,006,284,390.125,296,397,719.625,508,525,579.7725,022,331,486.69
流动负债:
短期借款354,371,906.571,130,116,873.251,172,306,616.941,039,743,103.15
应付票据及应付账款620,859,275.37703,410,867.1903,337,762.91,029,284,678.38
其中:应付票据95,442,845.1688,452,450.06129,357,261.29167,917,721.65
应付账款525,416,430.21614,958,417.04773,980,501.61861,366,956.73
合同负债237,507,441.67227,997,563.1252,964,296.82269,519,519.47
应付职工薪酬62,297,871.1759,493,634.4558,221,886.78104,817,928.71
应交税费113,184,344.96119,061,729.61273,125,387.05199,105,826.66
其他应付款合计463,554,853.84499,152,495.66521,765,382.49555,678,277.77
应付股利21,753,503.5630,127,944.383,353,503.563,353,503.56
一年内到期的非流动负债710,367,999.34551,122,320.17426,360,695.78498,035,202.06
其他流动负债65,538,130.7467,186,280.7161,837,673.5462,471,403.25
流动负债平衡项目0000
流动负债合计2,627,681,823.663,357,541,764.053,669,919,702.33,758,655,939.45
非流动负债:
长期借款2,860,653,053.852,290,905,446.631,621,958,601.671,542,190,754.84
应付债券1,592,677,302.711,576,429,482.661,560,193,176.691,560,810,898.63
租赁负债288,732,716.72292,088,819.62293,163,712.88269,967,672.04
递延收益148,406,712.28149,510,756.11152,908,690.26195,216,181.81
递延所得税负债186,831,475.44189,266,143.2200,610,810.1197,934,919.32
非流动负债平衡项目0000
非流动负债合计5,077,301,2614,498,200,648.223,828,834,991.63,766,120,426.64
负债平衡项目0000
负债合计7,704,983,084.667,855,742,412.277,498,754,693.97,524,776,366.09
所有者权益(或股东权益):
实收资本(或股本)1,880,610,5991,880,610,5581,880,610,4881,880,610,352
其他权益工具214,748,648.84214,748,806.19214,750,537.1214,751,048.51
资本公积3,527,580,539.853,518,190,904.223,461,952,337.453,464,665,903.83
减:库存股608,492,292.32555,923,164.15505,766,649.73431,064,877.67
其他综合收益-92,228,667.37-181,249,261.34-83,667,785.02-80,892,863.74
盈余公积732,541,206.45732,541,206.45732,541,206.45732,541,206.45
未分配利润10,142,517,243.2710,282,080,002.6710,677,253,567.2110,195,491,193.93
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计15,797,277,277.7215,890,999,052.0416,377,673,701.4615,976,101,963.31
少数股东权益1,504,024,027.721,549,656,255.291,632,097,184.411,521,453,157.29
股东权益平衡项目0000
股东权益合计17,301,301,305.4417,440,655,307.3318,009,770,885.8717,497,555,120.6
负债和股东权益合计25,006,284,390.125,296,397,719.625,508,525,579.7725,022,331,486.69
公告日期2024-10-262024-08-242024-04-202024-04-20
审计意见(境内)标准无保留意见
TOP↑